CAS 10476-85-4|Strontium chloride

Introduction:Basic information about CAS 10476-85-4|Strontium chloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Common NameStrontium chloride
CAS Number10476-85-4Molecular Weight158.526
Density3 g/mL at 25ºC(lit.)Boiling Point1250ºC
Molecular FormulaCl2SrMelting Point873ºC
MSDSChineseUSAFlash Point1250°C
Symbol
GHS05
Signal WordDanger

Names

Namestrontium dichloride
SynonymMore Synonyms

Chemical & Physical Properties

Density3 g/mL at 25ºC(lit.)
Boiling Point1250ºC
Melting Point873ºC
Molecular FormulaCl2Sr
Molecular Weight158.526
Flash Point1250°C
Exact Mass157.843323
LogP1.37900
Index of Refraction1.65
Storage condition2-8°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WK8400000
CHEMICAL NAME :
Strontium chloride
CAS REGISTRY NUMBER :
10476-85-4
LAST UPDATED :
199701
DATA ITEMS CITED :
19
MOLECULAR FORMULA :
Cl2-Sr
MOLECULAR WEIGHT :
158.52
WISWESSER LINE NOTATION :
SR G2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
405 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
222 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1874 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - changes in motor activity (specific assay) Gastrointestinal - hypermotility, diarrhea
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
908 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
148 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
2735 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - changes in motor activity (specific assay) Gastrointestinal - hypermotility, diarrhea
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
1067 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
5143 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - changes in motor activity (specific assay) Gastrointestinal - hypermotility, diarrhea
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
21798 mg/kg/17W-I
TOXIC EFFECTS :
Endocrine - changes in spleen weight Blood - change in clotting factors Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1579 mg/kg/35W-I
TOXIC EFFECTS :
Liver - liver function tests impaired Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
19432 mg/kg/35W-I
TOXIC EFFECTS :
Blood - change in clotting factors Endocrine - changes in adrenal weight Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases

MUTATION DATA

TEST SYSTEM :
Rodent - mouse
DOSE/DURATION :
260 mg/kg
REFERENCE :
BTERDG Biological Trace Element Research. (Humana Press Inc., POB 2148, Clifton, NJ 07015) V.1- 1979- Volume(issue)/page/year: 25,51,1990 *** REVIEWS *** TOXICOLOGY REVIEW FOREAE Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. Volume(issue)/page/year: 7,313,1942 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84462 No. of Facilities: 92 (estimated) No. of Industries: 6 No. of Occupations: 6 No. of Employees: 2018 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84462 No. of Facilities: 879 (estimated) No. of Industries: 13 No. of Occupations: 13 No. of Employees: 8289 (estimated) No. of Female Employees: 1266 (estimated)

Safety Information

Symbol
GHS05
Signal WordDanger
Hazard StatementsH318
Precautionary StatementsP280-P305 + P351 + P338
Personal Protective EquipmentEyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
Hazard CodesXi:Irritant
Risk PhrasesR37/38;R41
Safety PhrasesS26-S39
RIDADRNONH for all modes of transport
WGK Germany1
RTECSWK8400000
HS Code2827399000

Customs

HS Code2827399000

Articles31

More Articles
Novel Protamine-Based Polyelectrolyte Carrier Enhances Low-Dose rhBMP-2 in Posterolateral Spinal Fusion.

Spine 40 , 613-21, (2015)

A rodent posterolateral spinal fusion model.This study evaluated a protamine-based polyelectrolyte complex (PEC) developed to use heparin in enhancing the biological activity of low-dose recombinant h...

Strontium chloride Sr 89 for treating pain from metastatic bone disease.

Am. J. Health Syst. Pharm. 52(20) , 2189-95, (1995)

The role of strontium chloride Sr 89 in the palliative treatment of pain associated with metastatic bone disease is reviewed. Conventional therapies to relieve metastatic bone pain include nonopioid a...

[A case of lung cancer pain relief and safe return home by strontium chloride].

Gan To Kagaku Ryoho. 40(4) , 533-5, (2013)

Strontium chloride 89 (89Sr) is used as a systemic radiopharmaceutical therapy for the palliation of pain in patients with metastatic bone cancer. A 64-year-old man had previously undergone an operati...

Synonyms

MFCD00011249
EINECS 231-201-3
Strontium chloride
Strontium dichloride
Strontium Chloride, Anhydrous
CAS 10476-81-0|strontium bromide
CAS 10476-86-5|Strontium diiodide
Recommended......
TOP